Evidence map›Paper›PMID 28777255›Full record

ArticleJournal of cardiovascular pharmacology2017

Endogenous and Agonist-induced Opening of Mitochondrial Big Versus Small Ca2+-sensitive K+ Channels on Cardiac Cell and Mitochondrial Protection.

David F Stowe, Meiying Yang, James S Heisner, Amadou K S Camara

Open access · greenAbstract read
In one paragraph

Article in Journal of cardiovascular pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. Small-conductance CaThe Journal of physiology · 2026
    Review
  2. Article
  3. Application of Modulators of CaInternational journal of molecular sciences · 2025
    Article
  4. Article
  5. Luteolin-Induced Activation of Mitochondrial BKAntioxidants (Basel, Switzerland) · 2022
    Article
  6. Article
  7. Mitochondrial ion channels in cardiac function.American journal of physiology. Cell physiology · 2021
    Review
  8. Review
  9. Article
  10. Regulation of the Mitochondrial BKMolecules (Basel, Switzerland) · 2020
    Article
  11. Article
  12. Article
  13. Article
  14. Expression and Activation of BKFrontiers in cardiovascular medicine · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

David F StoweDepartments of *Anesthesiology and †Physiology, Medical College of Wisconsin, Milwaukee, WI; ‡Department of Biomedical Engineering, Marquette University and Medical College of Wisconsin, Milwaukee, WI; §Cardiovascular Center, Medical College of Wisconsin, Milwaukee, WI; and ¶Research Service, Zablocki VA Medical Center, Milwaukee, WI.
Meiying Yang
James S Heisner
Amadou K S Camara
Medical College of Wisconsin · US

Funding

Stem Cell CoreP01GM066730 · NIGMS · MEDICAL COLLEGE OF WISCONSIN · PI DASH, RANJAN K · 2003 to 2019
$23.6M
Differential cardioprotection by mitochondrial Ca2+ sensitive potassium channelsI01BX002539 · VA · CLEMENT J. ZABLOCKI VA MEDICAL CENTER · PI STOWE, DAVID F · 2016 to 2019
–
BLRD VA I01 BX002539NIGMS NIH HHS P01 GM066730
6 · The paper itself

Abstract

Both big (BKCa) and small (SKCa) conductance Ca-sensitive K channels are present in mammalian cardiac cell mitochondria (m). We used pharmacological agonists and antagonists of BKCa and SKCa channels to examine the importance of endogenous opening of these channels and the relative contribution of either or both of these channels to protect against contractile dysfunction and reduce infarct size after ischemia reperfusion (IR) injury through a mitochondrial protective mechanism. After global cardiac IR injury of ex vivo perfused Guinea pig hearts, we found the following: both agonists NS1619 (for BKCa) and DCEB (for SKCa) improved contractility; BKCa antagonist paxilline (PAX) alone or with SKCa antagonist NS8593 worsened contractility and enhanced infarct size; both antagonists PAX and NS8593 obliterated protection by their respective agonists; BKCa and SKCa antagonists did not block protection afforded by SKCa and BKCa agonists, respectively; and all protective effects by the agonists were blocked by scavenging superoxide anions (O2) with Mn(III) tetrakis (4-benzoic acid) porphyrin (TBAP). Contractile function was inversely associated with global infarct size. In in vivo rats, infusion of NS8593, PAX, or both antagonists enhanced regional infarct size while infusion of either NS1619 or DCEB reduced infarct size. In cardiac mitochondria isolated from ex vivo hearts after IR, combined SKCa and BKCa agonists improved respiratory control index and Ca retention capacity compared with IR alone, whereas the combined antagonists did not alter respiratory control index but worsened Ca retention capacity. Although the differential protective bioenergetics effects of endogenous or exogenous BKCa and SKCa channel opening remain unclear, each channel likely responds to different sensing Ca concentrations and voltage gradients over time during oxidative stress-induced injury to individually or together protect cardiac mitochondria and myocytes.

Indexed as

1-NaphthylamineAnimalsBenzimidazolesCardiotonic AgentsFemaleGuinea PigsMaleMitochondria, HeartMyocytes, CardiacPotassium Channels, Calcium-ActivatedRatsRats, Sprague-Dawley1-NaphthylamineBenzimidazolesCardiotonic AgentsNS 1619Potassium Channels, Calcium-Activated(R)-N-(benzimidazol-2-yl)-1,2,3,4-tetrahydro-1-naphthylamine

Identifiers

PMID28777255
PMCPMC5726766
OpenAlexW2743159557

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.